先天性甲状腺功能减退筛查指南(2014年修订版)

2016-04-23

Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1

中文标题:

先天性甲状腺功能减退筛查指南(2014年修订版)

英文标题:

Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).

发布机构:

发布日期:

2016-04-23

简要介绍:

Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).

Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

相关资料下载:
[AttachmentFileName(sort=100, fileName=先天性甲状腺功能减退筛查指南(2014年修订版))] GetToolGuiderByIdResponse(projectId=1, id=f06f91c001166870, title=先天性甲状腺功能减退筛查指南(2014年修订版), enTitle=Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision)., guiderFrom=, authorId=null, author=, summary=Guidelines&nbsp;for Mass Screening of Congenital&nbsp;Hypothyroidism&nbsp;(2014 revision).Purpose of developing the&nbsp;guidelines: Mass screening for congenital&nbsp;hypothyroidism&nbsp;started in 1, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Apr 23 22:44:20 CST 2016, originalUrl=, linkOutUrl=, content=<h1 style="font-size: 1.231em; margin: 0.375em 0px; line-height: 1.125em; font-family: arial, helvetica, clean, sans-serif;"><span class="highlight">Guidelines</span> for Mass Screening of Congenital <span class="highlight">Hypothyroidism</span> (2014 revision).</h1><div><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">Purpose of developing the </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">guidelines</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">: Mass screening for congenital </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">hypothyroidism</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;"> started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">treatment</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">hypothyroidism</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">. The disease requires continuous </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">treatment</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">treatment</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">. The </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">Guidelines</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;"> for Mass Screening of Congenital </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">Hypothyroidism</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;"> (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">guidelines</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;"> were revised in the current document (hereinafter referred to as the </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">Guidelines</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">). Target disease/conditions: Primary congenital </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">hypothyroidism</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">. Users of the </span><span class="highlight" style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">Guidelines</span><span style="font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17.9998px;">: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.</span></div>, tagList=[], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3251, appHits=159, showAppHits=11, pcHits=2251, showPcHits=1186, likes=177, shares=2, comments=0, approvalStatus=1, publishedTime=Sat Apr 23 14:44:20 CST 2016, publishedTimeString=2016-04-23, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Sat Apr 23 14:44:20 CST 2016, updatedBy=null, updatedName=null, updatedTime=Tue Dec 26 17:44:47 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=先天性甲状腺功能减退筛查指南(2014年修订版))])
先天性甲状腺功能减退筛查指南(2014年修订版)
下载请点击:
评论区 (0)
#插入话题